Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal L24 domain containing 1 pseudogene 5 (RSL24D1P5) is a human pseudogene, designated and approved by the HUGO Gene Nomenclature Committee (HGNC:37870), located in the human genome. Pseudogenes are segments of DNA similar to known genes but typically lack the ability to encode functional proteins due to mutations or truncations. RSL24D1P5 shows homology to the gene encoding ribosomal protein L24, but as a pseudogene, it does not produce a functional protein and is not considered a receptor, enzyme, transporter, or direct drug target. While there is growing evidence that pseudogenes can play roles in gene regulation—such as acting as competing endogenous RNAs or regulatory elements—no specific function, disease involvement, or interaction is yet attributed to RSL24D1P5. It is not referenced as a therapeutic target or physiological driver in current scientific or medical resources.
None established for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal L24 domain containing 1 pseudogene 5 (RSL24D1P5).